Aarovin Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 6 Year, 2 Days
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 78.36%
(FY 2022)
- Ebitda 78.36%
(FY 2022)
- Net Worth -23.71%
(FY 2022)
- Total Assets 6.19%
(FY 2022)
About Aarovin Pharmaceuticals
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Saravanakumar Arumugam and Gandhimathi Rathinasamy serve as directors at the Company.
- CIN/LLPIN
U74999TN2019PTC126952
- Company No.
126952
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aarovin Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saravanakumar Arumugam  | Director | 01-Feb-2022 | Current |
| Gandhimathi Rathinasamy | Director | 15-Jan-2019 | Current |
Financial Performance of Aarovin Pharmaceuticals.
Aarovin Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 78.36% increase in profit. The company's net worth observed a substantial decline by a decrease of 23.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarovin Pharmaceuticals?
Unlock access to Aarovin Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Movetowards Ryder Techno Private LimitedActive 2 years 8 months
Saravanakumar Arumugam and Gandhimathi Rathinasamy are mutual person
- Js Jobstick Technologies Private LimitedActive 1 year 6 months
Saravanakumar Arumugam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aarovin Pharmaceuticals?
Unlock and access historical data on people associated with Aarovin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarovin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarovin Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
